Category: Drug Safety Alerts
-
Parkinson’s Drug Permax Increases Risk of Cardiac Valve Regurgitation With Long-term Use
Authors of March 2007 Report Advise That Permax Use Should Be Stopped If Possible Due To Risk of Valvulopathy, Or Heart Valve Damage (Posted by Tom Lamb at DrugInjuryWatch.com) A new study published in…
-
Procrit, Epogen, And Aranesp: New “Black Box” Warnings Only First Part Of FDA’s Safety Re-evaluation
Popular Anemia Drugs Have Increased Risk Of Death, Blood Clots, Strokes, And Heart Attacks, Especially In Context Of Off-label Prescribing And Use (Posted by Tom Lamb at DrugInjuryWatch.com) On March 9, 2007 the FDA…
-
Big Pharma Has Its Way With The FDA Once Again As Regards Drug Safety
Agency Flops And Drops Its Proposed Drug Watch Site, Which Was Intended To Provide Early Warning About Emerging Unsafe Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2005 the FDA announced that they…
-
Ortho Evra Birth Control Patch Users Had Increased Risk Of Blood Clots
Large Study Shows Risk With The Patch Is Two Times Higher Than Observed In Women Using Birth Control Pill (Posted by Tom Lamb at DrugInjuryWatch.com) The February 2007 edition of the medical journal Obstetrics…
-
Blood Thinner Medication Warfarin Linked To Brain Bleeds In Elderly
Patients More Than 80 Years Old At An Increased Risk Of Intracerebral Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) The January 9, 2007 edition of the medical journal Neurology has a report concerning a…
-
Permax And Dostinex Significantly Increase Heart-Valve Damage Risk
January 2007: NEJM Reports That Studies Show Increased Risk Of Four To Seven Times At Normal Doses (Posted by Tom Lamb at DrugInjuryWatch.com) The January 4, 2007 issue of The New England Journal of…
-
Levaquin Associated With Blood Sugar Problems And Liver Disorders
January 2007 Article Sets Forth Reports Made To Health Canada In Past Ten Years (Posted by Tom Lamb at DrugInjuryWatch.com) The January 2, 2007 edition of the Canadian Adverse Reaction Newsletter (Volume 17, Issue…
-
Will FDA Restrict Use Of Ketek And Put Increased “Black Box” Warning On Sanofi-Aventis Antibiotic?
FDA Advisory Panel: Ketek Side Effects Risks Outweigh Benefits For Bronchitis And Sinusitis; Urges Patient Medication Guide When Used For Pneumonia In mid-December 2006, after two days of hearings, an FDA advisory panel recommended…